Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies
Frontiers in Pharmacology · 18.06.2024 · 15
DOI: 10.3389/fphar.2024.1368950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.06.2024. Verfasst von Aru Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic imbalance is the common basis of many diseases. As natural isoquinoline alkaloid, berberine (BBR) has shown great promise in regulating glucose and lipids metabolism and treating metabolic disorders. However, the related mechanism still lacks systematic research.
Aim
To discuss the role of BBR in the whole body’s systemic metabolic regulation and further explore its therapeutic potential and targets.
Method
Based on animal and cell experiments, the mechanism of BBR regulating systemic metabolic processes is reviewed. Potential metabolism-related targets were summarized using Therapeutic Target Database (TTD), DrugBank, GeneCards, and cutting-edge literature. Molecular modeling was applied to explore BBR binding to the potential targets.
Results
BBR regulates the whole-body metabolic response including digestive, circulatory, immune, endocrine, and motor systems through adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR), sirtuin (SIRT)1/forkhead box O (FOXO)1/sterol regulatory element-binding protein (SREBP)2, nuclear factor erythroid 2-related factor (Nrf) 2/heme oxygenase (HO)-1, and other signaling pathways. Through these reactions, BBR exerts hypoglycemic, lipid-regulating, anti-inflammatory, anti-oxidation, and immune regulation. Molecular docking results showed that BBR could regulate metabolism targeting FOXO3, Nrf2, NAD(P)H quinone oxidoreductase 1 (NQO1), glutathione peroxidase (Gpx) 4 and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA). Evaluating the target clinical effects, we found that BBR has the therapeutic potential of anti-aging, anti-cancer, relieving kidney disease, regulating the nervous system, and alleviating other chronic diseases.
Conclusion
This review elucidates the interaction between potential targets and small molecular metabolites by exploring the mechanism of BBR regulating metabolism. That will help pharmacologists to identify new promising metabolites interacting with these targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
- China Traditional Chinese Medicine Holdings Co. Limited, Guangdong e-fong Pharmaceutical Co., Ltd., Foshan, China.
- Graduate College, Beijing University of Chinese Medicine, Beijing, China.
- College of Basic Medical Sciences, Changchun University of Chinese Medicine, Changchun, China.
- Department of Endocrinology, Guang'anmen Hospital South Campus, China Academy of Chinese Medical Sciences, Beijing, China.
Zitieren
APA
Sun, A., Yang, H., Li, T., Luo, J., Zhou, L., Chen, R., Han, L., & Lin, Y. (2024). Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1368950
Vancouver
Sun A, Yang H, Li T, Luo J, Zhou L, Chen R, et al. Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1368950
BibTeX
@article{Sun2024,
author = {Sun, Aru and Yang, Haoyu and Li, Tao and Luo, Jinli and Zhou, Ling and Chen, Rui and Han, Lin and Lin, Yiqun},
title = {Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1368950}
}
EUVIMED